Clinical Trials on Solid Tumors With HRAS Alterations in Germany
Total 227 results
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Boehringer IngelheimActive, not recruitingSolid Tumors, KRAS Mutation; SOS1United States, Netherlands, Germany
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Novartis PharmaceuticalsCompletedSolid Tumor With p53 Wild Type StatusFrance, Germany, Singapore, Switzerland, United States
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of CologneBoehringer IngelheimCompleted
-
Silence Therapeutics GmbHCompleted
-
Glycotope GmbHCompleted
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Latvia
-
PfizerCompletedNeoplasms | Solid TumorsNetherlands, Germany
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
Glycotope GmbHGlycotope Biotechnology GmbHCompleted
-
BayerCompleted
-
University Hospital, EssenCompleted
-
Merck KGaA, Darmstadt, GermanyThreshold PharmaceuticalsCompleted
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
AmgenRecruitingAdvanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C MutationUnited States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor | CNS TumorFrance, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
-
Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsGermany
-
Pieris Pharmaceuticals GmbHFGK Clinical Research GmbHCompleted
-
Boehringer IngelheimCompletedMalignant Solid TumourGermany
-
Spirig Pharma Ltd.CompletedSkin Alterations Associated With Atopic DermatitisGermany
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
Novartis PharmaceuticalsCompletedSolid TumorsSpain, Canada, France, Denmark, Netherlands, Germany, Norway
-
Eli Lilly and CompanyActive, not recruitingRelapsed Solid Tumor | Refractory Solid TumorUnited States, Canada, France, Australia, Belgium, Germany, Spain, Italy
-
Glycotope GmbHCompletedSolid Tumor, AdultGermany, Italy, Spain
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificNorway, Germany
-
BayerActive, not recruitingSolid TumorsUnited States, Germany, Japan, Denmark
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
Glycotope GmbHCompleted
-
CatalYm GmbHRecruitingSolid Tumor, AdultSpain, Germany, Switzerland
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Spain, Germany, France, Israel, Italy, United Kingdom
-
Ganymed Pharmaceuticals GmbHCompletedSolid TumorsGermany, Switzerland, Latvia, Bulgaria, Lithuania
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Germany
-
University Hospital HeidelbergGerman Cancer Research CenterRecruitingSolid Tumor, AdultGermany
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsGermany, Spain, United Kingdom
-
Boehringer IngelheimRecruitingSolid TumorsUnited States, Spain, Germany, Austria, France, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
PfizerCompletedSolid TumorsUnited States, Taiwan, Japan, Korea, Republic of, Russian Federation, Hungary, France, Czechia, Germany, Italy, United Kingdom
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedSolid TumorsUnited States, China, Belgium, Australia, Italy, Korea, Republic of, Germany, Netherlands, Poland, Romania, Thailand
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
National Center for Tumor Diseases, HeidelbergMerck Sharp & Dohme LLC; University Hospital HeidelbergCompleted
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificGermany, France
-
Bristol-Myers SquibbCompletedSolid TumorsUnited States, Australia, Spain, Germany, France, Switzerland, Netherlands, Canada, Belgium, Italy